Jacqueline Whang-Peng
#84,160
Most Influential Person Now
Taiwanese-American physician-scientist
Jacqueline Whang-Peng's AcademicInfluence.com Rankings
Jacqueline Whang-Pengbiology Degrees
Biology
#5221
World Rank
#7650
Historical Rank
Molecular Biology
#1587
World Rank
#1615
Historical Rank
Jacqueline Whang-Pengphilosophy Degrees
Philosophy
#7957
World Rank
#11245
Historical Rank
Logic
#4989
World Rank
#6338
Historical Rank
Download Badge
Biology Philosophy
Jacqueline Whang-Peng's Degrees
- Doctorate Medicine National Taiwan University
- PhD Molecular Biology Stanford University
Why Is Jacqueline Whang-Peng Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jacqueline Jia-Kang Whang-Peng is a Taiwanese-American physician-scientist specialized in cytogenetics of cancer, as well as medical genetics, genetic oncology, and gene mapping. She was a researcher at the National Cancer Institute from 1960 to 1993.
Jacqueline Whang-Peng's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. (1988) (891)
- Nodal dissection for patients with gastric cancer: a randomised controlled trial. (2006) (599)
- Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. (1983) (545)
- Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). (1982) (465)
- PIK3CA as an oncogene in cervical cancer (2000) (457)
- Chromosome translocation in peripheral neuroepithelioma. (1984) (380)
- SECOND MALIGNANCIES COMPLICATING HODGKIN'S DISEASE IN REMISSION (1975) (328)
- A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). (1982) (321)
- Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme (2007) (319)
- Cytogenetic characterization of selected small round cell tumors of childhood. (1986) (317)
- Steroid‐free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV‐carriers with lymphoma (2003) (278)
- Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. (2005) (266)
- Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors. (1983) (208)
- Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. (2005) (184)
- Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination. (1980) (182)
- Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). (1968) (173)
- Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. (1988) (165)
- Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer (2004) (157)
- Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia. (1971) (157)
- Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin. (1984) (156)
- Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study. (1997) (154)
- Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells. (1978) (152)
- Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapy. (1979) (145)
- Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes (2006) (144)
- Induced hyperthermia in sedated humans and the concept of critical thermal maximum. (1978) (137)
- Cytogenetic studies in ovarian cancer. (1984) (133)
- Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Third International Workshop on Chromosomes in Leukemia. (1983) (130)
- Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications. (1977) (128)
- Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients. (1998) (120)
- Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia (1981) (114)
- Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up. (1985) (112)
- T‐Cell Lymphoblastic Lymphoma With Eosinophilia Associated With Subsequent Myeloid Malignancy (1992) (109)
- Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies. (1995) (107)
- Nonrandom structural and numerical chromosome changes in non‐small‐cell lung cancer (1991) (106)
- Cytogenetic studies in subgroups of rhabdomyosarcoma (1992) (103)
- Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. (1992) (103)
- Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer. (1983) (102)
- Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection (2012) (101)
- Cytogenetic studies in acute myelocytic leukemia with special emphasis on the occurrence of Ph1 chromosome. (1970) (100)
- Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein. (2005) (96)
- Chromosomal abnormalities in acute lymphoblastic leukemia: structural and numerical changes in 234 cases. (1981) (96)
- DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome. (1980) (96)
- Clinical implications of cytogenetic studies in cutaneous t‐cell lymphoma (CTCL) (1982) (93)
- Generation of Carcinoembryonic Antigen (CEA)-Specific T-Cell Responses in HLA-A*0201 and HLA-A*2402 Late-Stage Colorectal Cancer Patients after Vaccination with Dendritic Cells Loaded with CEA Peptides (2004) (88)
- Burkitt's lymphoma in AIDS: cytogenetic study. (1984) (87)
- Cytogenetic studies in non-African Burkitt lymphoma. (1980) (87)
- Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint region. (1987) (87)
- Cytogenetic studies in polycythemia vera. (1976) (86)
- Acute non‐lymphocytic leukemia and acute myeloproliferative syndrome following radiation therapy for non‐hodgkin's lymphoma and chronic lymphocytic leukemia. Cytogenetic studies (1979) (84)
- A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy. (2006) (82)
- Synthesis of kappa light chains by cell lines containing an 8;22 chromosomal translocation derived from a male homosexual with Burkitt's lymphoma. (1983) (82)
- Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial (2008) (80)
- Translocation t(11;22) in esthesioneuroblastoma. (1987) (77)
- Philadelphia-chromosome-positive preleukaemic state. (1972) (76)
- Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics. (1980) (74)
- Circulation of donor lymphocytes after blood transfusion in man. (1977) (71)
- Cytogenetic studies in acute lymphocytic leukemia: special emphasis in long-term survival. (1976) (70)
- Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia–Pacific region (2002) (69)
- Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies. (1989) (61)
- Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma (2013) (60)
- Phase II Randomized Trial of Erlotinib or Vinorelbine in Chemonaive, Advanced, Non-small Cell Lung Cancer Patients Aged 70 Years or Older (2012) (58)
- Phase II study of flutamide in the treatment of hepatocellular carcinoma (1996) (58)
- Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy. (1976) (58)
- Methodologic advances in the cytogenetic analysis of human solid tumors. (1986) (57)
- Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated. (2002) (56)
- Cross sectional study of use of alternative medicines in Chinese cancer patients. (1997) (55)
- The effect of daunomycin on human cells in vivo and in vitro (1969) (55)
- Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines. (1983) (52)
- Examination of human tumors for rhoA mutations. (1994) (51)
- An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer. (2001) (51)
- Cytogenetic studies in human T-cell lymphoma virus (HTLV)-positive leukemia-lymphoma in the United States. (1985) (51)
- Transplantable hepatomas induced in strain-2 guinea pigs by diethylnitrosamine: characterization by histology, growth, and chromosomes. (1969) (51)
- Chromosomal aberrations in two cases of inherited aplastic anemia with unusual clinical features. (1969) (51)
- Chronic granulocytic leukemia without the Philadelphia chromosome. (1976) (51)
- Cytogenetic findings in erythroleukemia. (1969) (50)
- Acute megakaryoblastic leukemia in childhood (1984) (50)
- A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (Stage IIIB/IV) non-small cell lung cancer. (2000) (50)
- Ultraviolet light-induced sister chromatid exchanges in xeroderma pigmentosum and in Cockayne's syndrome lymphocyte cell lines. (1978) (48)
- Erythroleukemia and other hematologic complications of intensive therapy in long‐term survivors of small cell lung cancer (1982) (48)
- Chronic granulocytic leukemia (CGL) during the course of chronic lymphocytic leukemia (CLL): correlation of blood, marrow, and spleen morphology and cytogenetics. (1974) (47)
- Microsatellite instability in sporadic‐colon‐cancer patients with and without liver metastases (1997) (47)
- Elevation of interleukin-10 levels in malignant pleural effusion. (1996) (47)
- Cytogenetic studies of esophageal carcinoma cell lines. (1990) (46)
- Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas. (1979) (46)
- A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late‐stage lung carcinoma (2005) (45)
- Molecular genetic characterization of neuroendocrine lung cancer cell lines. (1995) (45)
- Cytogenetic studies in 45 patients with acute lymphocytic leukemia. (1969) (45)
- The status of the do-not-resuscitate order in Chinese clinical trial patients in a cancer centre. (1999) (45)
- Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor. (2003) (43)
- Chromosomal instability in ataxia telangiectasia. (1982) (42)
- Absence of hereditary p53 mutations in 10 familial leukemia pedigrees. (1992) (42)
- Antcin B and its ester derivative from Antrodia camphorata induce apoptosis in hepatocellular carcinoma cells involves enhancing oxidative stress coincident with activation of intrinsic and extrinsic apoptotic pathway. (2011) (42)
- Renal cell carcinoma. Cytogenetic analysis of tumors and cell lines. (1995) (40)
- CYTOGENETICALLY ABNORMAL CELL S IN VITRO IN ACUTE LEUKÆMIA (1972) (40)
- Epithelial Origin of Polyoma Salivary Tumors in Mice: Evidence Based on Chromosome-Marked Cells (1971) (39)
- Cytogenetic studies and clinical implications in patients with Sézary syndrome (1976) (38)
- Complications Following D3 Gastrectomy: Post Hoc Analysis of a Randomized Trial (2005) (38)
- Anesthetic management of whole-body hyperthermia for the treatment of cancer. (1980) (37)
- A family with acute leukemia, hypoplastic anemia and cerebellar ataxia: association with bone marrow C-monosomy. (1978) (33)
- Cytogenetic study of two cases with lymphoma of mucosa-associated lymphoid tissue. (1994) (32)
- PD‐L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non–Small Cell Lung Cancer Patients with Malignant Pleural Effusion (2017) (32)
- An Evaluation of Liquid‐Crystal Thermometry as a Screening Device for Intraoperative Hyperthermia (1978) (32)
- Testicular feminization syndrome in three sibs: emphasis on gonadal neoplasia (1973) (31)
- Nephrotic syndrome associated with a clonal T-cell leukemia of large granular lymphocytes with cytotoxic function. (1986) (31)
- Stage migration influences on stage-specific survival comparison between D1 and D3 gastric cancer surgeries. (2005) (31)
- Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review. (1997) (30)
- Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions. (1998) (30)
- Peripheral neuroepithelioma: genetic analysis of tumor derived cell lines. (1985) (29)
- A Phase II Randomized Trial of Gefitinib Alone or with Tegafur/Uracil Treatment in Patients with Pulmonary Adenocarcinoma Who had Failed Previous Chemotherapy (2011) (29)
- Serum cytokine level fluctuations in chemotherapy-induced myelosuppression. (1996) (29)
- Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma (2008) (29)
- Development of a second clonally discrete Burkitt's lymphoma in a human immunodeficiency virus-positive homosexual patient. (1988) (29)
- Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy (2007) (29)
- Phase II Study of Docetaxel and Gemcitabine Combination Chemotherapy in Non–Small-Cell Lung Cancer Patients Failing Previous Chemotherapy (2002) (28)
- Phase II study of megestrol acetate in the treatment of hepatocellular carcinoma (1997) (28)
- Percutaneous Transhepatic Duodenal Drainage as an Alternative Approach in Afferent Loop Obstruction with Secondary Obstructive Jaundice in Recurrent Gastric Cancer (1998) (28)
- Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits. (2007) (28)
- 8 – Direct Chromosome Preparation of Bone Marrow Cells* (1974) (27)
- Cytogenetic studies of 21 patients with acute lymphoblastic leukemia in relapse. (1989) (26)
- Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms (2004) (26)
- alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma. (2005) (26)
- A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated (2004) (25)
- Report on essential thrombocythemia. (1981) (25)
- Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells. (1995) (24)
- Direct cytogenetic studies by needle aspiration of Burkitt's lymphoma in Ghana, West Africa. (1981) (24)
- Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma (2010) (24)
- Cell Cycle Characteristics, Maturation, and Phagocytosis In Vitro of Blast Cells From Patients With Chronic Myelocytic Leukemia (1971) (24)
- A Phase II Randomized Study of Paclitaxel Plus Carboplatin or Cisplatin against Chemo-Naive Inoperable Non-small Cell Lung Cancer in the Elderly (2006) (23)
- Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma (1997) (23)
- Dicentric Ph1 chromosome. (1973) (22)
- Current status of clinical studies for colorectal cancer in Taiwan. (2004) (22)
- Erlotinib has better efficacy than gefitinib in adenocarcinoma patients without EGFR-activating mutations, but similar efficacy in patients with EGFR-activating mutations. (2012) (22)
- Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II study. (2011) (21)
- Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy. (2000) (21)
- Leukemoid reaction resulting from multiple cytokine production in metastatic mucoepidermoid carcinoma with central necrosis. (1995) (21)
- A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older. (2003) (21)
- Loss of terminal deoxynucleotidyl transferase (TDT) activity as a predictor of emergence of resistance to chemotherapy in a case of chronic myelogenous leukemia in blast crisis (1979) (20)
- A phase I feasibility and pharmocokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions (1997) (20)
- Banding in leukemia: techniques and implications. (1977) (19)
- In vitro evaluation of GL331's cancer cell killing and apoptosis-inducing activity in combination with other chemotherapeutic agents (2000) (19)
- Translocation of c-sis protooncogene in peripheral neuroepithelioma. (1987) (19)
- Genesis of the Ph1 Chromosome (1974) (18)
- Cytogenetically abnormal cells in vitro in acute leukaemia. (1972) (18)
- A Phase I Study of Weekly Docetaxel, 24-Hour Infusion of High-Dose Fluorouracil/Leucovorin and Cisplatin in Patients with Advanced Gastric Cancer (2002) (18)
- A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly. (2008) (18)
- Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients. (2005) (18)
- A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan. (2007) (18)
- Pulmonary embolism after transcatheter arterial chemoembolization. (2005) (17)
- A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment (2016) (17)
- Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib. (2012) (17)
- Hyperthermia potentiates doxorubicin-related cardiotoxic effects. (1979) (17)
- Third‐line or fourth‐line chemotherapy in non‐small‐cell lung cancer patients with relatively good performance status (2011) (16)
- Cytogenetics of human small cell lung cancer. (1985) (16)
- A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated. (2005) (16)
- Serial cytogenetic studies of nonendemic Burkitt's lymphoma cell lines. (1980) (16)
- Circulating free mitochondrial DNA concentration and its association with erlotinib treatment in patients with adenocarcinoma of the lung (2014) (16)
- Phase II Study of Gemcitabine and Vinorelbine Combination Chemotherapy in Patients With Non–Small-Cell Lung Cancer Not Responding to Previous Chemotherapy (2003) (16)
- Small F chromosome in myelo- and lymphoproliferative diseases (1977) (15)
- Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer (2009) (15)
- Deletion of 3(p14p23) in secondary erythroleukemia arising in long-term survivors of small cell lung cancer. (1988) (15)
- Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer (1989) (15)
- Fatal hypereosinophilia with chromosome 15q- in a patient with multiple primary and familial neoplasms. (1983) (15)
- Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients (2002) (15)
- Primary pulmonary malignant hemangiopericytoma associated with coagulopathy. (1997) (15)
- Mutations in dominant and recessive oncogenes, and the expression of opioid and nicotine receptors in the pathogenesis of lung cancer (1991) (15)
- Guinea pig leukemia L2C: characterization of chromosomes and attempts to demonstrate antigenicity. (1970) (15)
- The prognostic value of serum cytokine levels in patients with acute infections. (1995) (14)
- So-called C marker chromosome and Epstein-Barr virus. (1970) (14)
- Acute lymphoblastic leukemia followed by chronic myelocytic leukemia. (1978) (14)
- Acquired XO/XY clones in bone marrow of a patient with paroxysmal nocturnal hemoglobinuria (PNH). (1976) (14)
- A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer. (2000) (14)
- A 20 Year Clinical and Laboratory Study of Familial B-Chronic Lymphocytic Leukemia in a Single Kindred. (1991) (13)
- Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8+ T cells (2004) (13)
- Lymphocytic leukaemias, acute and chronic. (1980) (13)
- A phase II study of carboplatin in nasopharyngeal carcinoma. (1997) (13)
- Culture of a cell line (NCLP-6) derived from a hepatocarcinoma induced in Macaca mulatta by N-nitrosodiethylamine. (1968) (13)
- 3p deletion and small cell lung carcinoma. (1989) (13)
- A myelodysplastic syndrome with marrow eosinophilia terminating in acute nonlymphocytic leukemia, associated with an abnormal chromosome 16. (1987) (13)
- The Transplacental Passage of Fetal Leukocytes into the Maternal Blood (1973) (12)
- Polyploidy in malignant melanoma (1970) (12)
- Maculopapular rashes secondary to gemcitabine injection for non-small-cell lung cancer. (1996) (12)
- In vitro Transformation of Cord Blood Lymphocytes by Antigens (1970) (12)
- A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non--small-cell lung cancer. (2000) (12)
- The Aurora Kinases Inhibitor VE-465 is a Novel Treatment for Glioblastoma Multiforme (2013) (11)
- Efficacy of chemotherapy in epidermal growth factor receptor (EGFR) mutated metastatic pulmonary adenocarcinoma patients who had acquired resistance to first-line EGFR tyrosine kinase inhibitor (TKI) (2016) (11)
- Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent. (2009) (11)
- Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes. (2002) (11)
- The Association Between Tumor Epidermal Growth Factor Receptor (EGFR) Mutation and Multiple Primary Malignancies in Patients With Adenocarcinoma of the Lungs (2015) (11)
- Maturation and phagocytosis by chronic myelogenous leukemia cells in vitro. A preliminary report. (1967) (10)
- Clinical trials of HCC in Taiwan. (1998) (10)
- Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma (2006) (10)
- Myeloproliferative syndromes: a unique presentation of chronic myelogenous leukemia (CML) as a primary tumor of bone. (1978) (10)
- First-line Systemic Therapy for Metastatic Non-small-cell Lung Cancer – A Review (2011) (10)
- Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48‐h infusion of fluorouracil/leucovorin for advanced pancreatic cancer (2006) (9)
- Ring chromosome in a case of acute myelomonocytic leukemia: its significance and a review of the literature. (1987) (9)
- Salvage Therapy for Chinese Non-small Cell Lung Cancer Patients Who Failed Previous Chemotherapy (2006) (8)
- Dicentric isochromosome for the long arm of chromosome #17, dic i(17q), in a patient with chronic myelogenous leukemia (CML). (1981) (8)
- Mutant lines of guinea pig L2C leukemia. II. Comparative cytogenetic studies and banding analyses of normal and leukemic karyotypes. (1976) (8)
- Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients. (2015) (8)
- The epidermal growth factor receptor‐tyrosine kinase inhibitor era has changed the causes of death of patients with advanced non‐small‐cell lung cancer (2013) (8)
- Neurofibromatosis: no chromosomal defect by prophase banding technique. (1984) (7)
- Phase I–II trial of weekly gemcitabine plus high‐dose 5‐fluorouracil and leucovorin in advanced pancreatic cancer (2006) (7)
- Involvement of chromosome No. 22 in neuroblastoma (1980) (7)
- Recessive oncogenes and chromosomal deletions in human lung cancer (1989) (7)
- Non-surgical treatment for afferent loop syndrome in recurrent gastric cancer complicated by peritoneal carcinomatosis: percutaneous transhepatic duodenal drainage followed by 24-hour infusion of high-dose fluorouracil and leucovorin. (2002) (7)
- A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan (2011) (7)
- Chromosomal characteristics of malignant lymphoma in northern pike (Esox lucius) from the United States. (1976) (7)
- Phase II randomized trial of erlotinib versus vinorelbine in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) aged ≥70 years in Taiwan. (2009) (7)
- A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy. (2006) (7)
- A prospective study of the use of circulating markers as predictors for epidermal growth factor receptor-tyrosine kinase inhibitor treatment in pulmonary adenocarcinoma. (2016) (7)
- Reutilization of Presumably Degraded Radioactive Label from a Chromosomal Fraction of Homologous and Heterologous Cells (1967) (7)
- A pharmacokinetic study with the high-dose anticancer agent menadione in rabbits. (1996) (7)
- Adjuvant Therapy for Thymic Carcinoma – A Decade of Experience in a Taiwan National Teaching Hospital (2016) (7)
- Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer. (1982) (7)
- Additive Effect of Interleukin-12 and Interleukin-18 on the T-helper Cell Pathway of Malignant Pleural Effusion (2002) (6)
- Rh mosaicism and aberrant MNSs antigen expression in a patient with chronic myelogenous leukemia. (1983) (6)
- Genes, Fragile Sites, Chromosomal Translocations, and Cancer in Aging (1985) (6)
- Cytogenetics of non-hodgkin's lymphomas (1997) (6)
- Brain metastasis features and association with tumor epidermal growth factor receptor mutation in patients with adenocarcinoma of the lung (2017) (6)
- Paclitaxel-induced severe neuropathy in patients with previous radiotherapy to the head and neck region. (1996) (6)
- Metastatic nasopharyngeal carcinoma with epidural spinal cord compression: report of an unusual and catastrophic event. (1995) (6)
- Chemotherapy for non-small cell lung cancer in elderly patients. (2005) (6)
- Unusual clonal evolution in a case of chronic myelogenous leukemia. (1976) (6)
- Paradoxical effect of GM‐CSF gene transfer on the tumorigenicity and immunogenicity of murine tumors (1998) (6)
- A phase-I trial of systemic heat and adriamycin (A) (1979) (6)
- Chromosome studies in HTLV-I, -II, and HIV-1, -2 cell lines infected in vivo and in vitro. (1993) (6)
- Transplantation of HL-A identical allogeneic bone marrow to a patient with acute lymphocytic leukemia. (1970) (5)
- Cytogenic studies in metastatic neuroblastoma. (1968) (5)
- Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: comparison of malignant and tuberculous pleural effusions. (2001) (5)
- Elevation of serum interleukin-6 levels before peak of serum granulocyte colony-stimulating factor level in chemotherapy-induced myelosuppressive patients. (1995) (5)
- Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy. (2008) (5)
- Continuous infusion cisplatin and etoposide chemotherapy for cancer of unknown primary site (CUPS) in Taiwan, a region with a high prevalence of endemic viral infections. (1998) (5)
- The eosinophilic variant of acute myelomonocytic leukemia developing as a secondary leukemia in a patient with mycosis fungoides. (1987) (4)
- The significance of body weight change in non-Hodgkins lymphoma. (1999) (4)
- Preliminary report of a randomized trial of different docetaxel schedules in non-small cell lung cancer patients failing previous chemotherapy. (2004) (4)
- Karyotypic derivation of H9 cell line. (1993) (4)
- Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer. (2000) (4)
- Survival Outcome of Inoperable Non-Small Cell Lung Cancer Patients Receiving Conventional Dose Epirubicin and Paclitaxel as First-Line Treatment (2005) (4)
- Chromosome studies in various neoplasms of domestic animals. (1969) (3)
- Combination chemotherapy with tamoxifen, ifosfamide, epirubicin and cisplatin in extensive-disease small-cell lung cancer. (2000) (3)
- Effect of Age on Pulmonary Metastases and Immunotherapy in Young and Middle‐aged Mice (2007) (3)
- Causes of induced hyperthermia. (1979) (3)
- Revisiting Squamous Cell Carcinoma of the Lungs-A Disease Given Less Attention (2009) (3)
- Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer. (1997) (3)
- Elevation of serum IL-6 levels in patients with acute bacterial infection. (1995) (3)
- Cytogenetic studies in L2C leukemia. (1977) (3)
- A non-random chromosomal abnormality del(3) (pl4-23) in small cell lung cancer (SCLC) (1983) (3)
- Hematuria induced by combination regorafenib and hyperthermia – a radiation recall effect (2019) (3)
- Critical Appraisal of Gefitinib in the Treatment of Non-Small Cell Lung Cancer (2015) (2)
- Induced Pluripotent Stem Cell–conditioned Medium Suppressed Melanoma Tumorigenicity Through the Enhancement of Natural-Killer Cellular Immunity (2016) (2)
- A phase II randomized placebo-controlled study investigating the combination of yiv-906 and sorafenib (SORA) in HBV (+) patients (Pts) with advanced hepatocellular carcinoma (HCC). (2020) (2)
- Palliative MEFLEP Therapy in Advanced Pancreatic Cancer: Excellent Response in a Patient with Her-2/neu Amplification (2002) (2)
- Chromosomes in cystic fibrosis. (1968) (2)
- Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy. (1981) (2)
- Development and Validation of an Instrument for the Measurement of Health-Related Quality of Life Based on View of Traditional Chinese Medicine Perspective (2012) (2)
- Cell cycl characteristics, maturation, and phagocytosis in vitro of blast cells from patients with chronic myelocytic leukemia. (1971) (1)
- ChromosomalCharacteristicsof Malignant Lymphomain Northern Pike (Esoxlucius) from the United States1 (1976) (1)
- 86 A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions (1997) (1)
- Zoledronic acid monotherapy improves osteoarticular involvement in SAPHO syndrome (2020) (1)
- RADIATION THERAPY FOR NON-HODGKIN'S (1979) (1)
- Genesis of the Ph chromosome. (1974) (1)
- 36 Gemcitabine has equivalent activity and lower toxicity compared with cisplatin + etoposide in advanced non-small cell lung cancer (NSCLC) (1997) (1)
- A Pilot Study of Taxol Treatment in Carcinoma of Unknown Primary Site: Preliminary Results (1994) (1)
- Erlotinib or Chemotherapy in Second-Line or Later Treatment of Tumor EGFR Wild-Type Pulmonary Adenocarcinoma Patients (2015) (1)
- Ifosfamide-based chemotherapy for previously treated lung cancer patients. (1998) (1)
- Weekly CAF chemotherapy for advanced breast cancer patients. (1997) (1)
- Lack of NK cells and related cytokines in pleural effusion. (1996) (1)
- myc Family oncogenes, autocrine growth factors, and chromosomal deletions in the pathogenesis of lung cancer (1987) (1)
- 0077 Reconstruction of exposed cohort and cumulative dose of radio-contaminated building residents for epidemiological study - Updated information (2014) (1)
- Cytogenetic Studies in Neoplasia (Human and Animal): Implications Prognosis, and Treatment (1989) (1)
- LONG‐TERM COMPLETE REMISSION OF METASTATIC GASTRIC CANCER AFTER WEEKLY DOCETAXEL, 24 H INFUSION OF HIGH‐DOSE 5‐FU/LEUCOVORIN AND CISPLATIN (2005) (1)
- Cytogenetic findings in the polycythemia vera: long-term follow-up in patients randomized to treatment by the Polycythemia Vera Study Group (1988) (0)
- Genes, chromosomal translocation, and neoplasia (1985) (0)
- Subcutaneous Panniculitis Like T Cell Lymphoma Complicated With Hemophagocytic Lymphohistiocytosis - A Challenging Case Report (2020) (0)
- Contents Vol. 68, 2005 (2005) (0)
- Cells From Patients With Chronic Myelocytic Leukemia Cell Cycle Characteristics, Maturation, and Phagocytosis In Vitro of Blast (2011) (0)
- Clinical trials for liver and pancreatic cancer in Taiwan (2007) (0)
- Index autorum ad Vol. 56, 1976 (1976) (0)
- APPLE News (2016) (0)
- Cytogenetic studies of the somatic and germ-line cells in sand rats (Psammomys obesus) (1970) (0)
- Chromosome 3P in small cell lung cancer (1988) (0)
- Reappraisal of the Early Diagnostic Value of Serial Analyses of Western Blot Patterns for HIV Infection in Neonates (1996) (0)
- Leukemia (CML) Clinical Implications of Cytogenetic Variants in Chronic Myelocytic (2011) (0)
- Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer. (1997) (0)
- Effect of age on tumor metastases and immunotherapy than the middle-aged mice after IV of B 16 melanoma cells (2007) (0)
- P2-245: A phase II trial of pemetrexed in non-small cell lung cancer patients failing previous platinum-based chemotherapy and with/without tyrosine-kinase treatment (2007) (0)
- Clones in Bone Marrow ofa Patient With Paroxysmal Nocturnal Hemoglobinuria ( PNH ) (2005) (0)
- Contents Vol. 84, 2013 (2013) (0)
- APPLE News (2015) (0)
- immunodeficiency virus-positive homosexual patient Development of a second clonally discrete Burkitt's lymphoma in a human (2012) (0)
- Apple News (2015) (0)
- Contents, Vol. 56, 1676 (1976) (0)
- APPLE News (2016) (0)
- Significance of chromosomal changes in patients of different age groups with acute leukemia. (1993) (0)
- A Pilot Study of Cisplatin, 5-Fluorouracil and High Dose Leucovorin in Chinese Patients with Head and Neck Cancer (1994) (0)
- Usage of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) in Tumor EGFR Wild-Type or Unknown Non-Small Cell Lung Cancer (2013) (0)
- Pemetrexed Treatment in Non-Small Cell Lung Cancer Patients Failing Previous Platinum-based Chemotherapy and with/without Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment (2008) (0)
- Subcutaneous Panniculitis Like T Cell Lymphoma Complicated with Hemophagocytic Lymphohistiocytosis-A Case Report (2020) (0)
- Chromosome analysis guidelines - preliminary report (2016) (0)
- nocturnal hemoglobinuria (PNH) Acquired XO/XY clones in bone marrow of a patient with paroxysmal (2011) (0)
- Erratum: Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer (Chinese Medical Journal (Taipei) (1997) 60 (67-73)) (1997) (0)
- Cytogenetic Studies in Non-African (2017) (0)
- Development of Medical Oncology in Taiwan (2007) (0)
- hypodiploidy and response to therapy Chemotherapy of the blastic phase of chronic granulocytic leukemia (2011) (0)
- Subject Index Vol. 68, 2005 (2005) (0)
- A phase II trial of UFUR plus gemcitabine in non-small cell lung cancer patients failing previous platinum-based chemotherapy (2005) (0)
- APPLE News (2016) (0)
- P3.02-070 Investigation of Whether HIF-1α Inhibitors Can Increase EGFR-TKI Effect for Non-Small Cell Lung Cancer Cell Lines (2017) (0)
- Phase II randomized study of gefitinib alone or plus UFUR treatment in Taiwanese patients with adenocarcinoma of the lung who failed at least two regimens (2008) (0)
- Phase II randomized study of gefitinib alone or plus vinorelbine every 2 weeks' treatment in patients with adenocarcinoma of the lung who failed at least two regimens. (2006) (0)
- FEEDBACK CONTROL OF ESOPHAGEAL TEMPERATURE DURING WHOLE BODY HYPERTHERMIA. (1978) (0)
- Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma (2010) (0)
- Apple News (2015) (0)
- 40 A phase II randomized trial of vinorelbine plus cisplatin ordocetaxel plus cisplatin in Inoperable, chemo-naïve non-small cell lung cancer patients (2005) (0)
- The atypical fluorescent body of the interphase nuclei of buccal mucosal cells and its relationship to the Y chromosome. (1978) (0)
- Chromosomal damage by radiation and anti-tumour agents (1984) (0)
- Cisplain, 5-Fluorouracil (5-FU), and Leucovorin(LV) in Refractory Gastric Cancer Patients (1994) (0)
- Index rerum ad Vol. 56, 1976 (1976) (0)
- Regulation of core body temperature during whole body hyperthermia by oesophageal temperature feedback (1980) (0)
- P3.07-011 Investigation of Autologous Tumor-Killing Effect of Effusion-Associated Lymphocytes in Malignant Pleural Effusion of Lung Cancer (2017) (0)
- A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment (2016) (0)
- P2-246: Phase II randomized study of vinorelbine alone or plus cisplatin against Chemo-naïve Inoperable Non-small Cell Lung Cancer in the Elderly (2007) (0)
- Patients Who Previously Responded to EGFR-TKI Treatment with Progression Responded to a Second EGFR-TKI Treatment after Challenge with Chemotherapy (2011) (0)
This paper list is powered by the following services:
Other Resources About Jacqueline Whang-Peng
What Schools Are Affiliated With Jacqueline Whang-Peng?
Jacqueline Whang-Peng is affiliated with the following schools:
